Spero Therapeutics Inc (SPRO)

0.9375 +0.01 (+1.59%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Spero Therapeutics Cash and Short Term Investments (Quarterly): 76.29M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
CytomX Therapeutics Inc 117.59M
Castle Biosciences Inc 279.78M
Arbutus Biopharma Corp 127.79M
PTC Therapeutics Inc 1.013B
Equillium Inc 25.88M